Pharming Group N.V. (PHAR): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $376.1M
- Net Income/Loss (FY2025)
- $2.5M
- Total Assets (FY2025)
- $500.0M
- Total Equity (FY2025)
- $277.1M
- Cash Flows from Operating Activities (FY2025)
- $54.7M
Source: Pharming Group N.V. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
